Table 5 Univariate analysis to determine factors related to decreased lung function (n = 239) IL interleukin, CCL C–C motif chemokine ligand, iNOS inducible nitric oxide synthase
Variables | AR (N = 126) | Comorbidity (N = 113) | P-value |
|---|---|---|---|
No paternal history of AR | 95 | 85 | 0.100 |
Paternal history of AR | 31 | 28 | |
No Maternal history of AR | 92 | 84 | 0.087 |
Maternal history of AR | 34 | 29 | |
IL-1β (≤ 10.84 pg/ml) | 57 | 68 | 0.027 |
IL-1β (> 10.84 pg/ml) | 68 | 45 | |
CCL24 (≤ 308.0 pg/ml) | 67 | 62 | 0.797 |
CCL24 (> 308.0 pg/ml) | 59 | 51 | |
iNOS (≤ 43.63 pg/ml) | 74 | 31 | < 0.001 |
iNOS (> 43.63 pg/ml) | 52 | 82 | |
E-cadherin (≤ 93.39 pg/ml) | 67 | 50 | 0.195 |
E-cadherin (> 93.39 pg/ml) | 59 | 63 | |
Vimentin (≤ 486.0 pg/ml) | 53 | 65 | 0.020 |
Vimentin (> 486.0 pg/ml) | 73 | 48 |